Visit us at our booth
We will be at the 49th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes ISPAD 2023 in Rotterdam from October 18-21. Visit us at our booth where we will present our innovative mylife Loop automated insulin delivery system powered by mylife CamAPS FX and share our latest news.
Attend the Ypsomed Symposium
Friday 20 October, 8:00am, Workshop Room Van Weelde Zaal
Automated insulin delivery with mylife CamAPS FX to manage type 1 diabetes in childhood and adolescence: practical insights
The use of mylife CamAPS FX in young children aged 1 to 7 years documented clinically and statistically significant reduction of HbA1c by 0.4%, and an increase in time in target glucose range by 9% without increasing time in hypoglycaemia below 3.9 mmol/L (70 mg/dL)1.
The use of the mylife CamAPS FX control algorithm in people aged 6 years and older including adults resulted in reduction of HbA1c by 0.4%, increased time in target glucose range by 11%, and reduced time in hypoglycaemia below 3.9 mmol/L (70 mg/dL) by 0.8%3. This signifies the importance and the ability of the CamAPS FX control algorithm to achieve desirable glucose control safely.
The mylife CamAPS FX app is approved for people with type 1 diabetes aged two years and over when used in combination with Dexcom G6 or aged four years and over when used in combination with FreeStyle Libre 3. Combine the mylife YpsoPump insulin pump, the mylife CamAPS FX mobile application and the CGM for an automated insulin delivery system (mylife Loop) managed directly from the smartphone.
Julia Ware is a clinical research fellow with the Artificial Pancreas Group under Prof Hovorka at the University of Cambridge, and paediatric registrar at Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust.
Dr Ware‘s current PhD research focuses on the impact of closed-loop technology on glycaemic control and quality of life in children and young people with type 1 diabetes.
Her special interest is in very young children with type 1 diabetes, and investigating how optimising new technologies might ease diabetes burden and improve outcomes in this vulnerable population.
She will give a presentation on the topic of: "Addressing the unmet needs to manage type 1 diabetes in children and adolescent".
Dr. Tauschmann was born in Graz in 1982. He studied human medicine at the Medical University of Graz from 2002 to 2009. After graduating, he worked as an assistant physician at the University Clinic for Paediatrics and Adolescent Medicine Graz, Department of General Paediatrics (headed by Prof. W. Muntean) and at the University Clinic for Internal Medicine, Department of Endocrinology and Diabetology (Prof. Dr. T. Pieber).
In September 2013, Dr Tauschmann moved to the University of Cambridge, where he worked as a Clinical Research Fellow at the Institute of Metabolic Science and also completed PhD studies at the Department of Pediatrics, University of Cambridge.
In July 2018, he moved to the Clinical Department of Paediatric Pulmonology and Endocrinology at the Univ. Clinic for Paediatrics and Adolescent Medicine, where he is currently in training to become a consultant paediatrician.
He will give a presentation on the topic of: "Management of challenging situations with mylife CamAPS FX system AID system".